The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 1996

Primary Completion Date

December 31, 1997

Study Completion Date

December 31, 1997

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Lamivudine

DRUG

Stavudine

DRUG

Zidovudine

Trial Locations (8)

11794

SUNY at Stony Brook / Division of Infectious Diseases, Stony Brook

33612

Univ of South Florida, Tampa

77006

Houston Clinical Research Network / Div of Montrose Clinic, Houston

84132

Univ of Utah / School of Medicine / Div of Infect Dis, Salt Lake City

90502

Harbor UCLA Med Ctr, Torrance

Unknown

Sunnybrook Health Science Ctr, North York

Montreal Gen Hosp / Div of Clin Immuno and Allergy, Montreal

00927

Univ of Puerto Rico School of Medicine, San Juan

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY